Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00233259 · ClinicalTrials.gov registry record · NA
Lifestyle Modification Program to Reduce Risk of Coronary Heart Disease in Latina Women With Diabetes
A NA study, sponsored by Oregon Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 273
- Enrollment target
NCT00233259: Completed NA study, sponsored by Oregon Research Institute.
NCT00233259 is a NA study that has completed, run by Oregon Research Institute. The registered enrollment target is 273 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00233259, a NA study, has completed, sponsored by Oregon Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 273 participants
- Enrollment target
Study Summary
The Viva Bien! trial will comprehensively evaluate a multiple risk factor intervention (diet, physical activity, stress management, social support, and smoking cessation) in a randomized effectiveness trial, which will be offered in English and Spanish to diabetic Latinas.
Interventions
- BEHAVIORAL Stress Management
- BEHAVIORAL Physical Activity
- BEHAVIORAL Smoking Cessation
- BEHAVIORAL Social Support
- BEHAVIORAL Mediterranean Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 273 participants |
| Start Date | 2006-03 |
| Est. Completion | 2010-08 |
| Phase | NA |
What the finished NCT00233259 record still lists
NCT00233259 is an interventional study that assigns participants to a tested intervention. The registered 273 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 5 interventions - of which Stress Management is the first listed.
NCT00233259 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00233259 about?
NCT00233259 is a clinical study titled "Lifestyle Modification Program to Reduce Risk of Coronary Heart Disease in Latina Women With Diabetes". The Viva Bien! trial will comprehensively evaluate a multiple risk factor intervention (diet, physical activity, stress management, social support, and smoking cessation) in a randomized effectiveness trial, which will be offered in English and Spanish to diabetic Latinas.
What is the current status of trial NCT00233259?
This trial is currently completed. It is a NA study. The enrollment target is 273 participants. The study started on 2006-03. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00233259?
The interventions under investigation include: Stress Management (BEHAVIORAL), Physical Activity (BEHAVIORAL), Smoking Cessation (BEHAVIORAL), Social Support (BEHAVIORAL), Mediterranean Diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT00233259?
This trial is sponsored by Oregon Research Institute, which has 62 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00233259's enrollment target sits among peer trials
273 386th of 2000 higher than 1,614 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07229430 · 273 participants · NA
Safety and Effectiveness Evaluation of the High-intensity Focused Ultrasound Device for Lifting Lax Submental and Neck Tissue
- NCT03808922 · 274 participants · Phase 3
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- NCT04573504 · 274 participants · Phase 4
Antibiotics for Severe Perineal Laceration to Prevent Infection Following Repair
- NCT05289557 · 274 participants · Phase 3
The Efficacy and Safety of Bonjesta® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia